TNFSF10 and neoplasm: This design aims to combat metastasis by intercepting circulating tumor cells (CTCs), as PLTs tend to aggregate at sites of injury or tumor interaction, thereby enabling the direct delivery of cytotoxic TRAIL to the CTCs [108].